News
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
Heidelberg Pharma AG reports significant progress in the first quarter of 2026 financially and in clinical development, completion of Phase I clinical trial, milestone payments triggered, and extended cash reach -
-
-
COMMUNIQUÉ DE PRESSE
Blue Cap AG successfully concludes fiscal year 2025 and proposes record dividend of EUR 1.60 per share
Blue Cap AG reports successful fiscal year 2025 with record dividend proposal of EUR 1.60 per share and robust financial performance. Forecast for 2026 confirmed amid market challenges -
-
COMMUNIQUÉ DE PRESSE
VIB Vermögen AG: Positive business development continued in the 2025 financial year
VIB Vermögen AG's positive business development continued in the 2025 financial year, achieving all targets with increased FFO and gross rental income. Company diversified portfolio and guidance for 2026 shared -
-
-
COMMUNIQUÉ DE PRESSE
FORVIA HELLA publishes first-quarter 2026 results: Sales at prior-year level, robust earnings development, guidance confirmed
FORVIA HELLA reports stable sales in Q1 2026 at €1.9 billion, with growth in Electronics and Lifecycle Solutions, decline in Lighting business. Operating income at €96 million, net cash flow improved to -2.5%. Company confirms guidance for 2026
